Literature DB >> 4130214

Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.

M E Harper, A Pike, W B Peeling, K Griffiths.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4130214     DOI: 10.1677/joe.0.0600117

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


× No keyword cloud information.
  20 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  Review of assessment of total androgen blockade as treatment of metastatic prostate cancer.

Authors:  J Geller
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

Review 3.  Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.

Authors:  Hui Zhu; Jorge A Garcia
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 4.  Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.

Authors:  Elahe A Mostaghel; Peter S Nelson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

5.  A systematic study of testosterone metabolism in benign prostatic hypertrophy (BPH): in vitro results.

Authors:  J E Altwein; F Orestano
Journal:  Urol Res       Date:  1975

6.  Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.

Authors:  W M van Weerden; A van Kreuningen; E P Moerings; F H de Jong; G J van Steenbrugge; F H Schröder
Journal:  Urol Res       Date:  1991

7.  Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.

Authors:  C D Schiller; M R Schneider; H Hartmann; A H Graf; H Klocker; G Bartsch
Journal:  Urol Res       Date:  1991

8.  Current management of prostate cancer: dilemmas and trials.

Authors:  C O'Hanlon Brown; J Waxman
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 9.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

10.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.